Search

Since the appearance of the COVID-19 pandemic (at the end of 2019, Wuhan, China), the recognition of COVID-19 with medical imaging has become an active research topic for the machine learning and computer vision community. This paper is based on the results obtained from the 2021 COVID-19 SPGC challenge, which aims to classify volumetric CT scans into normal, COVID-19, or community-acquired pneumonia (Cap) classes. To this end, we proposed a deep-learning-based approach (CNR-IEMN) that consists of two main stages. In the first stage, we trained four deep learning architectures with a multi-tasks strategy for slice-level classification. In the second stage, we used the previously trained models with an XG-boost classifier to classify the whole CT scan into normal, COVID-19, or Cap classes. Our approach achieved a good result on the validation set, with an overall accuracy of 87.75% and 96.36%, 52.63%, and 95.83% sensitivities for COVID-19, Cap, and normal, respectively. On the other hand, our approach achieved fifth place on the three test datasets of SPGC in the COVID-19 challenge, where our approach achieved the best result for COVID-19 sensitivity. In addition, our approach achieved second place on two of the three testing sets. [ABSTRACT FROM AUTHOR]

Life was once normal before the first announcement of COVID-19's first case in Wuhan, China, and what was slowly spreading became an overnight worldwide pandemic. Ever since the virus spread at the end of 2019, it has been morphing and rapidly adapting to human nature changes which cause difficult conundrums in the efforts of fighting it. Thus, researchers were steered to investigate the virus in order to contain the outbreak considering its novelty and there being no known cure. In contribution to that, this paper extensively reviewed, compared, and analyzed two main points; SARS-CoV-2 virus transmission in humans and detection methods of COVID-19 in the human body. SARS-CoV-2 human exchange transmission methods reviewed four modes of transmission which are Respiratory Transmission, Fecal–Oral Transmission, Ocular transmission, and Vertical Transmission. The latter point particularly sheds light on the latest discoveries and advancements in the aim of COVID-19 diagnosis and detection of SARS-CoV-2 virus associated with this disease in the human body. The methods in this review paper were classified into two categories which are RNA-based detection including RT-PCR, LAMP, CRISPR, and NGS and secondly, biosensors detection including, electrochemical biosensors, electronic biosensors, piezoelectric biosensors, and optical biosensors. [ABSTRACT FROM AUTHOR]

The coronavirus pandemic, also known as the COVID-19 pandemic, is an ongoing virus. It was first identified on December 2019 in Wuhan, China, and later spread to 192 countries. As of now, 251,266,207 people have been affected, and 5,070,244 deaths are reported. Due to the growing number of COVID-19 patients, the demand for COVID wards is increasing. Telemedicine applications are increasing drastically because of convenient treatment options. The healthcare sector is rapidly adopting telemedicine applications for the treatment of COVID-19 patients. Most telemedicine applications are developed for heterogeneous environments and due to their diverse nature, data transmission between similar and dissimilar telemedicine applications is a difficult task. In this paper, we propose a Tele-COVID system architecture design along with its security aspects to provide the treatment for COVID-19 patients from distance. Tele-COVID secure system architecture is designed to resolve the problem of data interchange between two different telemedicine applications, interoperability, and vendor lock-in. Tele-COVID is a web-based and Android telemedicine application that provides suitable treatment to COVID-19 patients. With the help of Tele-COVID, the treatment of patients at a distance is possible without the need for them to visit hospitals; in case of emergency, necessary services can also be provided. The application is tested on COVID-19 patients in the county hospital and shows the initial results. [ABSTRACT FROM AUTHOR]

Since its first description in Wuhan, China, the novel Coronavirus (SARS-CoV-2) has spread rapidly around the world. The management of this major pandemic requires a close coordination between clinicians, scientists, and public health services in order to detect and promptly treat patients needing intensive care. The development of consumer wearable monitoring devices offers physicians new opportunities for the continuous monitoring of patients at home. This clinical case presents an original description of 55 days of SARS-CoV-2-induced physiological changes in a patient who routinely uses sleep-monitoring devices. We observed that sleep was specifically affected during COVID-19 (Total Sleep time, TST, and Wake after sleep onset, WASO), within a seemingly bidirectional manner. Sleep status prior to infection (e.g., chronic sleep deprivation or sleep disorders) may affect disease progression, and sleep could be considered as a biomarker of interest for monitoring COVID-19 progression. The use of habitual data represents an opportunity to evaluate pathologic states and improve clinical care. [ABSTRACT FROM AUTHOR]